Efect of chemotherapy timing in triple‐negative breast cancer: a real‐world evidence study

Purpose: Triple-negative breast cancer (TNBC) is an aggressive, heterogeneous malignancy with poor prognosis. The optimal timing of chemotherapy-neoadjuvant (NACT) versus adjuvant (ACT)-remains controversial. This study assessed real-world outcomes in non-metastatic TNBC patients according to chemot...

Full description

Autores:

Rodríguez Jaramillo, Carlos Andrés
Zapata Muñoz, Maycos Leandro
González Ramírez, Diego Mauricio
Graciano, Noiver
López, Lucelly
Montoya, Katherine
Gómez, Luis Rodolfo
Cortés, Javier

Tipo de recurso:

Article of investigation

Fecha de publicación:

2025

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/46272

Acceso en línea:

https://hdl.handle.net/10495/46272

Palabra clave:

Quimioterapia
Antineoplastic Combined Chemotherapy Protocols
Protocolos de Quimioterapia Combinada Antineoplásica
Chemotherapy
Quimioterapia
Neoadjuvant Therapy
Terapia Neoadyuvante
Neoplasm Staging
Estadificación de Neoplasias
Prognosis
Pronóstico
Retrospective Studies
Estudios Retrospectivos
Time Factors
Factores de Tiempo
Triple Negative Breast Neoplasms
Neoplasias de la Mama Triple Negativas
https://id.nlm.nih.gov/mesh/D000971
https://id.nlm.nih.gov/mesh/D004358
https://id.nlm.nih.gov/mesh/D020360
https://id.nlm.nih.gov/mesh/D009367
https://id.nlm.nih.gov/mesh/D011379
https://id.nlm.nih.gov/mesh/D012189
https://id.nlm.nih.gov/mesh/D013997
https://id.nlm.nih.gov/mesh/D064726
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades

Rights

openAccess

License

http://creativecommons.org/licenses/by/4.0/